Alessia Di Costanzo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study	ATHEROSCLEROSIS	2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions	DRUGS	2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?	ATHEROSCLEROSIS	2025
Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly	DRUGS	2025
Lomitapide-induced fatty liver is a reversible condition: evidence from a case of familial chylomicronemia syndrome	JOURNAL OF CLINICAL LIPIDOLOGY	2025
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia	JAMA CARDIOLOGY	2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY	2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment	STAR PROTOCOLS	2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice?	CURRENT ATHEROSCLEROSIS REPORTS	2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia.	LIVER INTERNATIONAL	2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study	LA RADIOLOGIA MEDICA	2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis	CIRCULATION	2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis	CIRCULATION	2023
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study	THE LANCET	2022
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease	BIOMEDICINES	2022
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway	BIOMOLECULES	2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content	ATHEROSCLEROSIS	2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study	FRONTIERS IN GENETICS	2022